Found 1565 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: Pkinase_Tyr

Total Genus Sequence Length pdb Title
87 294 6rfiA Irak4 in complex with inhibitor
92 291 6in0A Crystal structure of epha3 in complex with 18-crown-6
91 299 6iupA Crystal structure of fgfr4 kinase domain in complex with compound 5
88 289 6nvhA Fgfr4 complex with n-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide
85 289 6nviA Fgfr4 complex with n-(3-chloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-5-fluorophenyl)acrylamide
83 303 6nvlA Fgfr1 complex with n-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide
86 290 6nvjA Fgfr4 complex with n-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-fluorophenyl)acrylamide
85 290 6nvgA Fgfr4 complex with n-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)phenyl)acrylamide
81 289 6nvkA Fgfr4 complex with blu-554, n-((3s,4s)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2h-pyran-4-yl)acrylamide
99 307 6mweA Crystal structure of tie2 in complex with decipera compound dp1919
86 269 6hm6A Crystal structure of spleen tyrosine kinase (syk) in complex with a 2-(pyridinyloxymethyl)pyridine inhibitor
89 306 6hmxA Rip2 kinase catalytic domain complex with n(4,5dimethyl1hpyrazol3yl)7methoxy6(2methylpropane2sulfonyl)quinolin4amine
89 271 6hm7A Crystal structure of spleen tyrosine kinase (syk) in complex with a 2-(phenoxymethyl)pyridine inhibitor
81 270 6mibA Crystal structure of the ilk atp-binding deficient mutant (l207w)/alpha-parvin core complex
90 288 6hd4A Abl1 in complex with compound 7 and imatinib (sti-571)
86 299 6ferA Crystal structure of human ddr2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1h-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-n-(2,2,2-trifluoroethyl)acetamide
94 303 6fimA Ddr1, 2-[8-(1h-indazole-5-carbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-n-methylacetamide, 1.440a, p1211, rfree=24.1%
90 301 6elrA Human jak1 kinase domain in complex with compound 7
86 287 6dudA Jak3 with cyanamide cp12
92 303 6finA Ddr1, 3-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]-8-(1h-indazole-5-carbonyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1.670a, p1211, rfree=22.8%
87 287 6db4A Jak3 with cyanamide cp34
92 271 6di0A Crystal structure of btk in complex with fragment ligand
99 309 6fioA Ddr1, 2-[1'-(1h-indazole-5-carbonyl)-4-methyl-2-oxospiro[indole-3,4'-piperidine]-1-yl]-n-(2,2,2-trifluoroethyl)acetamide, 1.990a, p6522, rfree=27.7%
84 285 6da4A Jak3 with cyanamide cp10
95 307 6fiqA Ddr1, 1-(1h-indazole-5-carbonyl)-5'-methoxy-1'-[2-oxo-2-[(2s)-2-(trifluoromethyl)pyrrolidin-1-yl]ethyl]spiro[piperidine-4,3'-pyrrolo[3,2-b]pyridine]-2'-one, 1.790a, p212121, rfree=23.8%
93 301 6fexA Ddr1, 2-[4-bromo-2-oxo-1'-(1h-pyrazolo[4,3-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-n-(2,2,2-trifluoroethyl)acetamide, 1.291a, p212121, rfree=17.4%
91 271 6di1A Crystal structure of btk in complex with covalent fragment ligand
95 303 6filA Ddr1, 2-[8-(1h-indazole-5-carbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-n-methylacetamide, 1.730a, p212121, rfree=24.5%
84 287 6db3A Jak3 with cyanamide cp23
94 303 6fewA Ddr1, 2-[8-(1h-indazole-5-carbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-n-methylacetamide, 1.440a, p1211, rfree=24.1%
87 264 6blnA Btk complex with compound 13
88 266 6bkwA Btk complex with compound 12
87 263 6bkhA Btk complex with compound 11
91 309 6brjA Ddr1 bound to vx-680
92 309 6bsdA Ddr1 bound to dasatinib
86 264 6bikA Btk complex with compound 7
82 264 6bkeA Btk complex with compound 10
86 269 6npuA C-abl kinase domain with the activator(cmpd29), n-(1-(3,4-dichlorophenyl)-4,5-dihydro-1h-pyrazol-3-yl)acetamide
88 269 6npeA C-abl kinase domain with the activator(cmpd6), 2-cyano-n-(4-(3,4-dichlorophenyl)thiazol-2-yl)acetamide
88 269 6npvA C-abl kinase domain with the activator(cmpd51), n-(1-(3,4-dichlorophenyl)-4-(2-hydroxyethyl)-4,5-dihydro-1h-pyrazol-3-yl)isonicotinamide
100 302 5qinA Tgf-beta receptor type 2 kinase domain in complex with n- {4-[3-(6-methoxypyridin-3-yl)-1h-pyrrolo[3,2-b]pyridin-2- yl]pyridin-2-yl}acetamide
89 271 6n9pA Discovery of affinity-based probes for btk occupancy assay
79 268 6nfiA Btk in complex with inhibitor n-(3-{[(2,6-dimethylphenyl)methyl]amino}-7-methoxyindeno[1,2-c]pyrazol-6-yl)methanesulfonamide
90 271 6nfhA Btk in complex with inhibitor 8-(2,3-dihydro-1h-inden-5-yl)-2-({4-[(2s)-3-(dimethylamino)-2-hydroxypropoxy]phenyl}amino)-5,8-dihydropteridine-6,7-dione
94 307 6mx8A Crystal structure of anaplastic lymphoma kinase (alk) bound by brigatinib
85 302 6mzqA Tas-120 in reversible binding mode with fgfr1
84 275 6i8zA Crystal structure of ptk2 in complex with bi-4464.
77 262 6mnyA Crystal structure of mouse btk kinase domain in complex with compound 9a
83 302 6mzwA Tas-120 covalent complex with fgfr1
100 296 6n8gA Irak4 bound to benzoxazole compound